LEP and obesity due to melanocortin 4 receptor deficiency: Several experimental studies have shown that, despite obesity, models in which the expression of leptin or leptin receptors was inhibited did not exhibit an increased risk of mammary cancer [79,80,81], suggesting that leptin signaling plays a crucial role in tumorigenesis rather than weight gain itself.